This journal is not listed in the SCIE, SSCI, AHCI, ESCI, Scopus or JCR 2024 lists. That does not make it unreliable, but check its indexing, peer review and fees carefully.
How to spot predatory journals →01Impact factor
Impact factor of GEMATOLOGIYA I TRANSFUZIOLOGIYA (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers GEMATOLOGIYA I TRANSFUZIOLOGIYA published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is not listed in JCR 2024, so it has no official Journal Impact Factor from Clarivate; the value above is how often its recent papers are cited.
Rank in its subject categories
- Hematologyrank 91 of 104 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of GEMATOLOGIYA I TRANSFUZIOLOGIYA
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). GEMATOLOGIYA I TRANSFUZIOLOGIYA is not listed in JCR 2024, so it has no JCR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Open access.
Is your paper a fit for GEMATOLOGIYA I TRANSFUZIOLOGIYA?
Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.
Check my paper for this journalOr find journals that fit my paper
Need a faster review? The fastest journals in Hematology accept papers in a median of 48 days.
APC waivers and discounts for GEMATOLOGIYA I TRANSFUZIOLOGIYA
No published waiver policy found for its publisher. Ask the editorial office, and compare publishers that do waive the APC.
02Funders
Who funds research published in GEMATOLOGIYA I TRANSFUZIOLOGIYA
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
03Indexing
Indexing of GEMATOLOGIYA I TRANSFUZIOLOGIYA
| List | Status |
|---|---|
| Science Citation Index Expanded (SCIE) | Not listed |
| Social Sciences Citation Index (SSCI) | Not listed |
| Arts & Humanities Citation Index (AHCI) | Not listed |
| Emerging Sources Citation Index (ESCI) | Not listed |
| Scopus | Not listed |
| Journal Citation Reports 2024 | Not listed |
- ISSN
- 0234-5730
- eISSN
- 2411-3042
- Subjects
- Hematology
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
04How to submit
How to submit to GEMATOLOGIYA I TRANSFUZIOLOGIYA
- Read the guide for authors. It sets the article types, word limit, reference style and file format that GEMATOLOGIYA I TRANSFUZIOLOGIYA accepts. You find it on the journal's website, usually under "For authors".
- Format to the journal's style. Check whether it wants a Word file, a LaTeX file or a PDF for the first submission, and follow its reference style; many journals accept any clear format at first and ask for their style only after acceptance. If the language or structure needs work first, manuscript editing by a PhD editor in your field is priced by word count (see the editing cost guide).
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. GEMATOLOGIYA I TRANSFUZIOLOGIYA is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
05Reviewer comments
Reviewer comments and rejection reasons for GEMATOLOGIYA I TRANSFUZIOLOGIYA
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to GEMATOLOGIYA I TRANSFUZIOLOGIYA, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Worried about the English? Manuscript editing by editors in your subject: see the price →
Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds06Same subject
Hematology journals with a similar impact factor*
The journals next to GEMATOLOGIYA I TRANSFUZIOLOGIYA when the 103 journals of Hematology in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 87 | Hematological Oncology | 0.66 | SCIE | Subscription |
| 88 | Research and Practice in Thrombosis and Haemostasis | 0.62 | SCIE | Fully open access |
| 89 | Leukemia Research Reports | 0.47 | ESCI | Fully open access |
| 90 | Iraqi Journal of Hematology | 0.45 | ESCI | Fully open access |
| 92 | Case Reports in Hematology | 0.43 | ESCI | Fully open access |
| 93 | Indian Journal of Hematology and Blood Transfusion | 0.41 | SCIE | Subscription |
| 94 | Transfusion Clinique et Biologique | 0.39 | SCIE | Subscription |
| 95 | The American Journal of Hematology | 0.33 | SCIE | Subscription |
*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.
Is GEMATOLOGIYA I TRANSFUZIOLOGIYA right for your paper? Find the right journal
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 157,375 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.
07Questions
Frequently asked questions
What is the impact factor of GEMATOLOGIYA I TRANSFUZIOLOGIYA?
Based on ScholarsColab citation data (October 2026), the 2-year impact factor of GEMATOLOGIYA I TRANSFUZIOLOGIYA is 0.45: papers it published in the two previous years were cited 0.45 times on average in a year. The journal is not listed in JCR 2024, so it has no official Clarivate Journal Impact Factor.
What is the h-index of GEMATOLOGIYA I TRANSFUZIOLOGIYA?
The h-index of GEMATOLOGIYA I TRANSFUZIOLOGIYA is 10 (October 2026): 10 of its papers have each been cited at least 10 times. Its i10-index is 12.
What is the quartile of GEMATOLOGIYA I TRANSFUZIOLOGIYA?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). GEMATOLOGIYA I TRANSFUZIOLOGIYA is not listed in JCR 2024, so it has no JCR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is GEMATOLOGIYA I TRANSFUZIOLOGIYA indexed in Scopus?
GEMATOLOGIYA I TRANSFUZIOLOGIYA is not listed in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is GEMATOLOGIYA I TRANSFUZIOLOGIYA an SCIE journal?
GEMATOLOGIYA I TRANSFUZIOLOGIYA is not listed in SCIE or the other Web of Science indexes, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is GEMATOLOGIYA I TRANSFUZIOLOGIYA in Journal Citation Reports (JCR)?
GEMATOLOGIYA I TRANSFUZIOLOGIYA is not listed in the JCR 2024 list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Who funds research published in GEMATOLOGIYA I TRANSFUZIOLOGIYA?
0% of 76 recent research articles in GEMATOLOGIYA I TRANSFUZIOLOGIYA name a funder.
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Japanese Journal Of Applied Physics
- Astronomy and Astrophysics
- Nature Communications
- Materials Science and Engineering: A
- Remote Sensing
- Applied Optics
- Industrial and Engineering Chemistry Research
- Physical Chemistry Chemical Physics
- Journal of Colloid and Interface Science
- Science of the Total Environment
- Physical Review C
- IEEE Transactions on Magnetics
- Materials Letters
- Organic Letters
Browse all journals: indexing, impact factor and reviewer comments →